Event agenda

Registration and welcome coffee

Welcome by Flanders Vaccine

Opening lecture – Setting the Scene: Exploring Delivery Routes: Impact on Immune Response, Challenges, and Emerging Trends – Bert Devriendt, GHENT UNIVERSITY

Cationic polymers as non-viral vectors - Richard Hoogenboom, University of Ghent

The development of next generation cationic polymers as non-viral gene delivery vectors will be discussed, going beyond L-PEI.

A COVID-19 mucosal vaccine formulation adjuvanted with Bacillus subtilis spores - University of Hasselt

The SARS-CoV-2 receptor-binding domain (RBD) coadministered with Bacillus subtilis spores through the nasal route induces robust humoral and cellular, both mucosal and systemic immune responses in mice.

Intradermal vaccination: our Belgian experience - Patrick Soentjens, Institute of Tropical Medicine (ITM)

We will highlight our experiences with different intradermal vaccine schedules against rabies, tick borne encephalitis, mpox and covid-19.

Short talks Academia Q&A

Coffee Break

Skin vaccination: challenges and opportunities – Vanessa Vankerckhoven, IDEVAX

Skin vaccination offers a promising avenue in vaccine delivery. The talk will provide insights into delivery methods, immune response, stability, scalability, and regulatory hurdles, as well as clinical data.

A reducible carbamate ionizable lipid library tailored towards intramuscular and systemic therapeutic applications – Bram Bogaert, ETHERNA

In this presentation, we report on the development of a novel series of ionizable lipids based on a reducible biscarbamate linker that are suited for multiple prophylactic and therapeutic applications.

Routes of administration: perspectives from the veterinary field – Dieter Vancraeynest, ZOETIS

The veterinary field is confronted with very diverse animal species and often needs to mass administer vaccines at low cost. This talk will cover various routes of administration – focusing on opportunities and challenges.

Plant-made edible vaccines: A new approach for oral immunization – Jeroen Hofenk, SWIFTPHARMA

The edible vaccine is a new development that allows the introduction of desired genes into plants. They offer many advantages such as ease of manufacture, storage, cost- effectiveness, and better accessibility and acceptability by people globally.

Short talks Companies Q&A

Networking reception